Functional Distinctions of Endometrial Cancer-Associated Mutations in the Fibroblast Growth Factor Receptor 2 Gene.
a disintegrin and metalloprotease 17 (ADAM17)
endometrial cancer (EC)
epidermal growth factor receptor (EGFR)
fibroblast growth factor receptor 2 (FGFR2)
heparin-binding EGF-like growth factor (HB-EGF)
Journal
Cells
ISSN: 2073-4409
Titre abrégé: Cells
Pays: Switzerland
ID NLM: 101600052
Informations de publication
Date de publication:
07 09 2023
07 09 2023
Historique:
received:
05
07
2023
revised:
25
08
2023
accepted:
04
09
2023
medline:
23
10
2023
pubmed:
28
9
2023
entrez:
28
9
2023
Statut:
epublish
Résumé
Functional analysis of somatic mutations in tumorigenesis facilitates the development and optimization of personalized therapy for cancer patients. The
Identifiants
pubmed: 37759450
pii: cells12182227
doi: 10.3390/cells12182227
pmc: PMC10526318
pii:
doi:
Substances chimiques
Receptor, Fibroblast Growth Factor, Type 2
EC 2.7.10.1
Mitogen-Activated Protein Kinases
EC 2.7.11.24
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : NCI NIH HHS
ID : P30 CA086862
Pays : United States
Références
Int J Mol Sci. 2022 Oct 24;23(21):
pubmed: 36361585
J Clin Oncol. 2018 Jan 20;36(3):276-282
pubmed: 29182496
Science. 2011 Mar 25;331(6024):1553-8
pubmed: 21436442
Transl Cancer Res. 2020 Dec;9(12):7706-7715
pubmed: 35117373
PLoS One. 2012;7(2):e30801
pubmed: 22383975
Cell. 2013 Mar 28;153(1):17-37
pubmed: 23540688
Clin Cancer Res. 2017 Jan 15;23(2):549-561
pubmed: 27489286
FASEB J. 2020 Apr;34(4):4956-4969
pubmed: 32103528
Nature. 2007 Mar 8;446(7132):153-8
pubmed: 17344846
Clin Cancer Res. 2019 May 1;25(9):2699-2707
pubmed: 30745300
Curr Probl Cancer. 2017 Jan - Feb;41(1):37-47
pubmed: 28041631
Wiley Interdiscip Rev Dev Biol. 2015 May-Jun;4(3):215-66
pubmed: 25772309
Proc Natl Acad Sci U S A. 2008 Jun 24;105(25):8713-7
pubmed: 18552176
Physiol Rev. 2010 Oct;90(4):1507-46
pubmed: 20959622
Nature. 2022 Aug;608(7923):609-617
pubmed: 35948633
J Cell Sci. 2010 Nov 15;123(Pt 22):3913-22
pubmed: 20980382
J Cancer. 2020 Oct 21;11(24):7264-7275
pubmed: 33193890
Science. 2013 Mar 29;339(6127):1546-58
pubmed: 23539594
Lancet Oncol. 2015 Jun;16(6):686-94
pubmed: 25981814
PLoS One. 2009;4(3):e4734
pubmed: 19266047
Nat Commun. 2011;2:229
pubmed: 21407195
Learn Mem. 2004 Jul-Aug;11(4):373-8
pubmed: 15286179
PLoS Comput Biol. 2017 Feb 2;13(2):e1005360
pubmed: 28151998
Cancers (Basel). 2021 Nov 06;13(21):
pubmed: 34771725
Oncogene. 2007 Nov 1;26(50):7158-62
pubmed: 17525745
Int J Mol Sci. 2021 Mar 20;22(6):
pubmed: 33804608
Lancet Oncol. 2020 May;21(5):671-684
pubmed: 32203698
J Cell Biol. 2004 Jun 21;165(6):893-902
pubmed: 15197174
Clin Transl Med. 2023 May;13(5):e1223
pubmed: 37165578
Methods Mol Biol. 2006;327:99-113
pubmed: 16780215
Gynecol Oncol. 2017 May;145(2):366-373
pubmed: 28314589
Cancer Treat Rev. 2014 May;40(4):507-12
pubmed: 24332498
Ann Oncol. 2022 May;33(5):522-533
pubmed: 35176457
J Clin Oncol. 2015 Oct 20;33(30):3401-8
pubmed: 26324363
J Cell Biol. 2004 Mar 1;164(5):769-79
pubmed: 14993236
Nat Commun. 2016 Jan 04;7:10262
pubmed: 26725515
J Cell Biochem. 2003 Jun 1;89(3):440-9
pubmed: 12761878
Future Oncol. 2009 Feb;5(1):27-32
pubmed: 19243295
Microbiol Mol Biol Rev. 2011 Mar;75(1):50-83
pubmed: 21372320
Adv Cancer Res. 2004;91:69-136
pubmed: 15327889
Cancer Cell Int. 2020 Oct 21;20:516
pubmed: 33100908
Cancers (Basel). 2019 Aug 21;11(9):
pubmed: 31438559
Mol Cell Biol. 1989 Mar;9(3):1263-70
pubmed: 2725497
Proc Natl Acad Sci U S A. 2013 Jul 9;110(28):11433-8
pubmed: 23801765
Biochem J. 2009 Apr 28;420(1):105-13
pubmed: 19207106
Cancer Res. 2009 Jun 1;69(11):4573-6
pubmed: 19487280
J Clin Med. 2020 Jun 17;9(6):
pubmed: 32560580
Oncogenesis. 2017 Apr 24;6(4):e323
pubmed: 28436990
PLoS One. 2012;7(12):e52795
pubmed: 23300780